These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial. Caroff SN; Walker P; Campbell C; Lorry A; Petro C; Lynch K; Gallop R J Clin Psychiatry; 2007 Mar; 68(3):410-5. PubMed ID: 17388711 [TBL] [Abstract][Full Text] [Related]
23. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia. Lohr JB; Caligiuri MP J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552 [TBL] [Abstract][Full Text] [Related]
24. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study. Bai YM; Yu SC; Lin CC J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949 [TBL] [Abstract][Full Text] [Related]
25. Factors related to tardive dyskinesia. Chouinard G; Annable L; Ross-Chouinard A; Nestoros JN Am J Psychiatry; 1979 Jan; 136(1):79-82. PubMed ID: 31802 [TBL] [Abstract][Full Text] [Related]
26. Vulnerability to tardive dyskinesia. Wolf ME; DeWolfe AS; Ryan JJ; Lips O; Mosnaim AD J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257 [TBL] [Abstract][Full Text] [Related]
27. GABA system: clinical research and treatment of tardive dyskinesia. Thaker GK; Hare TA; Tamminga CA Mod Probl Pharmacopsychiatry; 1983; 21():155-67. PubMed ID: 6419061 [No Abstract] [Full Text] [Related]
28. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)]. Arushanian EB Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951 [No Abstract] [Full Text] [Related]
29. Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesia. Andersson U; Häggström JE; Nilsson MI; Widerlöv E Psychopharmacology (Berl); 1988; 94(2):167-71. PubMed ID: 2895483 [TBL] [Abstract][Full Text] [Related]
30. Propranolol for tardive dyskinesia and extrapyramidal side effects (pseudoparkinsonism) from neuroleptics. Kulik FA; Wilbur R Psychopharmacol Bull; 1980 Jul; 16(3):18-9. PubMed ID: 6105690 [No Abstract] [Full Text] [Related]
31. Effect of des-tyrosine-gamma-endorphin in tardive dyskinesia. Casey DE; Korsgaard S; Gerlach J; Jørgensen A; Simmelsgaard H Arch Gen Psychiatry; 1981 Feb; 38(2):158-60. PubMed ID: 7011248 [TBL] [Abstract][Full Text] [Related]
32. Neurochemical findings in the cerebrospinal fluid of schizophrenic patients with tardive dyskinesia and neuroleptic-induced parkinsonism. Saito T; Ishizawa H; Tsuchiya F; Ozawa H; Takahata N Jpn J Psychiatry Neurol; 1986 Jun; 40(2):189-94. PubMed ID: 2431183 [TBL] [Abstract][Full Text] [Related]
33. Effects of tiapride in tardive dyskinesia. Pollak P; Gaio JM; Hommel M; Pellat J; Perret J Psychopharmacology (Berl); 1985; 85(2):236-9. PubMed ID: 3925489 [TBL] [Abstract][Full Text] [Related]
35. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements. Brown KW; White T Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study. Libov I; Miodownik C; Bersudsky Y; Dwolatzky T; Lerner V J Clin Psychiatry; 2007 Jul; 68(7):1031-7. PubMed ID: 17685739 [TBL] [Abstract][Full Text] [Related]